Real-world effectiveness and safety of eculizumab in AQP4-IgG-positive neuromyelitis optica spectrum disorder.
Koc ER, Yetkin MF, Saridas F, Turan OF, Sevim S, Terzi M, Sen S, Tutuncu M, Uygunoglu U, Kurtuncu M, Gunduz T, Tepe N, Canbaz-Kabay S, Efendi H, Bunul SD, Cetinkaya-Tezer D, Gungor-Dogan İ, Demir S, Altunrende B, Kale-Icen N, Omerhoca S, Kamisli O, Demir CF, Karakurum-Yuksel B, Uzunkopru C, Beckmann Y, Cilingir V, Agan K, Gumus H, Ercan M, Kocer B, Gluscevic S, Carnero-Contentti E, Casallas-Vanegas A, Camera V, Calabrese M, Ozkaya G, Akman-Demir G, Boz C, Altıntas A, Siva A.
Koc ER, et al. Among authors: gluscevic s.
J Neurol. 2026 Jan 8;273(1):67. doi: 10.1007/s00415-025-13608-w.
J Neurol. 2026.
PMID: 41504930
Free PMC article.